ClearPoint Neuro (CLPT) Total Current Liabilities (2011 - 2026)
ClearPoint Neuro (CLPT) reported Total Current Liabilities of $9.5 million for Q1 2026, up 38.07% on a YoY basis from $6.9 million in Q1 2025, and down 11.94% sequentially from $10.8 million in Q4 2025.
ClearPoint Neuro (CLPT) Total Current Liabilities (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 16 years of Total Current Liabilities data on file, last reported at $9.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 38.07% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (up 38.07% YoY), and the FY2025 full-year result was $10.8 million, up 3.98% from the prior year.
- Total Current Liabilities eased to $9.5 million in Q1 2026, from $10.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $16.7 million in Q2 2024 to a low of $4.0 million in Q1 2022.
- A 5-year average of $8.2 million and a median of $7.4 million in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 169.17% in 2024 and tumbled 55.68% in 2025, its largest moves.
- Tracing CLPT's Total Current Liabilities over 5 years: stood at $6.8 million in 2022, then grew by 9.46% to $7.4 million in 2023, then surged by 39.34% to $10.4 million in 2024, then climbed by 3.98% to $10.8 million in 2025, then decreased by 11.94% to $9.5 million in 2026.
- Business Quant data shows CLPT's Total Current Liabilities at $9.5 million in Q1 2026, $10.8 million in Q4 2025, and $8.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 9.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.48 Mn |
| Dec 31, 2025 | 10.77 Mn |
| Sep 30, 2025 | 8.05 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 10.35 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 16.69 Mn |
| Mar 31, 2024 | 15.16 Mn |
| Dec 31, 2023 | 7.43 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Dec 31, 2022 | 6.79 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Jun 30, 2022 | 5.48 Mn |
| Mar 31, 2022 | 3.97 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 4.59 Mn |
| Jun 30, 2021 | 4.39 Mn |